Roach's Introductory Clinical Pharmacology 11th Edition Test Bank | Complete Practice Q&A for Nursing Students

TESTBANK FOR ROACHES INTRODUCTORY CLINICAL P
M M M M M


HARMACOLOGY 11TH EDITION M M




MULTIPLE CHOICE M



1. AMnursingMinstructorMisMpreparingMaMteachingMplanMforMaMgroupMofMnursingMstudentsMab
outMpharmacology.MWhenMdescribingMthisMtopic,MtheMinstructorMwouldMfocusMtheMdiscus
sionMonMwhichMofMtheMfollowingMasManMessentialMaspect?
A) DrugMname
B) DrugMclass
C) DrugMaction
D) DrugMsourc
eMAns:M CMFeedba
ck:
PharmacologyMisMtheMstudyMofMdrugsMandMtheirMactionMonMlivingMorganisms.MThus,ManMe
ssentialMaspectMofMpharmacologyMisMdrugMaction.MAnMunderstandingMofMtheMdrugMname,M
drugMclass,MandMdrugMsourceMisMimportant,MbutMtheMmostMcriticalMaspectMrelatedMtoMphar
macologyMisMhowMtheMdrugMactsMinMtheMbody.


2. AMnursingMstudentMisMpreparingMtoMadministerMaMprescribedMdrugMtoMaMpatient.MTheMstud
entMreviewsMinformationMaboutMtheMdrugMandMitsMactions.MWhichMofMtheMfollowingMwoul
dMbeMtheMbestMchoiceMforMobtainingMthisMinformation?MSelectMallMthatMapply.
A) NursingMinstructor
B) NurseMassignedMtoMtheMpatient
C) ClinicalMdrugMreference
D) PrescribingMhealthMcareMprovider
E) ClinicalMpharmacist
MAns:MC,ME

Feedback:
AlthoughMtheMnursingMstudentMcanMaskMtheMnursingMinstructor,MtheMnurseMassignedMtoMt
heMpatient,MandMtheMprescribingMhealthMcareMproviderMforMinformationMaboutMtheMdrug,Mt
heMbestMchoicesMforMdrugMinformationMwouldMincludeManMappropriateMdrugMreferenceMa
ndMtheMclinicalMpharmacist.


3. WhenMdescribingMtheMvariousMtypesMofMmedicationsMtoMaMgroupMofMnursingMstudent
s,MaMnursingMinstructorMwouldMidentifyMwhichMofMtheMfollowingMasMaMsourceMforMd
erivingMmedications?MSelectMallMthatMapply.
A) Plants
B) SyntheticMsources
C) Mold
D) Minerals
E) AnimalsMAn
s:MA,MB,MC,MD,ME
Feedback:
MedicationsMareMderivedMfromMnaturalMsources,MforMexample,Mplants,Mmolds,Mminerals,MandMa
nimals,MasMwellMasMcreatedMsyntheticallyMinMaMlaboratory.

MedConnoisseur

,4. WhichMofMtheMfollowingMnamesMmayMbeMassignedMtoMaMdrugMduringMtheMproces
sMofMdevelopment?MSelectMallMthatMapply.
A) ChemicalMname
B) OfficialMname
C) PharmacologicMname
D) TradeMname
E) NonproprietaryMname
MAns:M A,MB,MD,ME

Feedback:
ThroughoutMtheMprocessMofMdevelopment,MdrugsMmayMhaveMseveralMnamesMassignedMtoM
themMincludingMaMchemicalMname,MaMgenericM(nonproprietary)Mname,ManMofficialMname,M
andMaMtradeMorMbrandMname.


5. AMdrugMmayMbeMclassifiedMbyMwhichMofMtheMfollowing?M SelectMallMthatMapply.
A) TheMchemicalMtypeMofMtheMdrug'sMactiveMingredient
B) TheMwayMtheMdrugMisMusedMtoMtreatMaMspecificMcondition
C) TheMgenericMnameMofMtheMdrug
D) TheMtradeMnameMofMtheMdrug
E) TheMnonproprietaryMnameMofMtheMdru
gMAns:MA,MB
Feedback:
AMdrugMmayMbeMclassifiedMbyMtheMchemicalMtypeMofMtheMactiveMingredientMorMbyMtheMwa
yMitMisMusedMtoMtreatMaMparticularMcondition.MGeneric,Mtrade,MandMnonproprietaryMreferMto
MhowMaMdrugMisMnamed.




6. AMgroupMofMnursingMstudentsMareMreviewingMinformationMaboutMtheMprocessMofMdrug
MdevelopmentMinMtheMUnitedMStates.MTheMstudentsMdemonstrateMunderstandingMofMthi

sMprocessMwhenMtheyMidentifyMthatMwhichMofMtheMfollowingMcategoriesMareMassignedM
byMtheMFoodMandMDrugMAdministrationMtoMnewlyMapprovedMdrugs?MSelectMallMthatMa
pply.
A) Metabolite
B) NoncontrolledMsubstance
C) Prescription
D) Nonprescription
E) ControlledMsubstance
MAns:MC,MD,ME

Feedback:
OnceMdrugsMareMapprovedMforMuse,MtheMFDAMassignsMtheMdrugMtoMoneMofMtheMfollowing
Mcategories:Mprescription,Mnonprescription,MorMcontrolledMsubstance.MMetaboliteMrefersMt

oMtheMinactiveMformMofMtheMdrug.MNoncontrolledMsubstanceMisMaMtermMthatMisMnotMused.




PageM 2

,7. WhichMofMtheMfollowingMwouldMbeMmostMimportantMforMtheMnurseMtoMdoMtoMensureMthe
MsafeMuseMofMprescriptionMdrugsMinMtheMinstitutionalMsetting? MSelectMallMthatMapply.

A) AdministeringMdrugs
B) MonitoringMclientsMforMdrugMeffects
C) PrescribingMdrugs
D) EvaluatingMclientsMforMtoxicMeffects
E) EducatingMclients/caregiversMaboutMdrug
sMAns:MA,MB,MD,ME
Feedback:
InMtheMinstitutionalMsetting,MtheMnurse'sMroleMtoMensureMsafeMuseMofMprescriptionMdrugsMi
ncludesMadministeringMdrugs,MmonitoringMdrugMeffects,MevaluatingMforMtoxicMeffects,Man
dMeducatingMclientsMandMcaregiversMaboutMdrugs.


8. TheMnurseMisMhelpingMaMclientMreviewMaMprescriptionMfromMtheMhealthMcareMprovider.M
WhenMexaminingMtheMprescription,MwhichMofMtheMfollowingMwouldMtheMnurseMexpectMt
oMfindMdocumented?MSelectMallMthatMapply.
A) NameMofMtheMdrug
B) DosageMofMtheMdrug
C) RouteMofMdrugMadministration
D) TimesMofMdrugMadministration
E) LicensedMprescriber'sMsignatur
eMAns:MA,MB,MC,MD,ME
Feedback:
TheMprescriptionMmustMcontainMtheMclient'sMname,MtheMnameMofMtheMdrug,MtheMdosage,Mth
eMmethodMandMtimesMofMadministration,MandMtheMsignatureMofMtheMlicensedMhealthMcareM
providerMprescribingMtheMdrug.


9. AfterMteachingMaMgroupMofMnursingMstudentsMaboutMnonprescriptionMdrugs,MtheMnursing
MinstructorMdeterminesMthatMtheMteachingMwasMsuccessfulMwhenMtheMstudentsMidentifyMw

hichMofMtheMfollowing?MSelectMallMthatMapply.
A) TheyMrequireMaMlicensedMhealthMcareMprovider'sMsignature.
B) TheyMareMreferredMtoMasMover-the-counterMdrugs.
C) TheyMcanMbeMtakenMwithoutMriskMtoMtheMclient.
D) TheyMhaveMcertainMlabelingMrequirements.
E) TheyMshouldMbeMtakenMonlyMasMdirectedMonMtheMlab
el.MAns:MB,MD,ME
Feedback:
NonprescriptionMdrugsMareMoftenMreferredMtoMasMover-the-
counterM(OTC)Mdrugs.MTheyMdoMnotMrequireMaMprescriptionM(aMlicensedMhealthMcareMpro
vider'sMsignature)MbutMdoMnotMcomeMwithoutMriskMtoMtheMclient.MTheMfederalMgovernment
MhasMimposedMlabelingMrequirementsMofMOTCMdrugsMandMtheyMshouldMonlyMbeMtakenMas

MdirectedMonMtheMlabelMunlessMunderMtheMsupervisionMofMaMhealthMcareMprovider.




PageM 3

, 10. AMnursingMstudentMisMreviewingMinformationMaboutMtheMControlledMSubstancesMActM
ofM1970.MTheMstudentMwouldMexpectMtoMfindMwhichMofMtheMfollowingMasMbeingMregula
tedMforMdrugsMclassifiedMasMcontrolledMsubstances?MSelectMallMthatMapply.
A) Manufacturing
B) Elimination
C) Distribution
D) Formulation
E) Dispensing
MAns:MA,MC,ME

Feedback:
TheMControlledMSubstancesMActMofM1970MregulatesMtheMmanufacture,Mdistribution,MandM
dispensingMofMdrugsMclassifiedMasMcontrolledMsubstances.MEliminationMrefersMtoMtheMexc
retionMofMdrugsMfromMtheMbody,MaMpharmacokineticMactivity.MTheMactMdoesMnotMaddressM
formulationMofMtheMdrug.


11. WhenMreviewingMinformationMaboutMtheMOrphanMDrugMProgram,MwhichMofMtheMfollow
ingMwouldMtheMnurseMexpectMtoMfind?MSelectMallMthatMapply.
A) TheMprogramMencouragesMtheMdevelopmentMandMmarketingMofMproductsMtoMtreatMr
areMdiseases.
B) TheMprogramMgrantsMprovisionalMapprovalMwithMaMwrittenMcommitmentMfromM
theMdrugMcompanyMtoMformallyMdemonstrateMclientMbenefits.
C) TheMprogramMprovidesMforMincentives,MsuchMasMresearchMgrants,MprotocolMassistan
ce,MandMspecialMtaxMcredits,MtoMdevelopMproductsMtoMtreatMrareMdiseases.
D) TheMprogramMgrantsM7MyearsMofMexclusiveMmarketingMrightsMtoMtheMmanufacture
rMifMapproved.
E) TheMprogramMacceleratesMapprovalMofMdrugsMbasedMonMpreliminaryMevidenceMbef
oreMformalMdemonstrationMofMclientMbenefits.
Ans:M A,MC,MD
Feedback:
TheMOrphanMDrugMProgramMencouragesMtheMdevelopmentMandMmarketingMofMproductsMu
sedMtoMtreatMrareMdiseases.MTheMprogramMprovidesMincentivesMtoMencourageMmanufactur
ersMtoMdevelopMorphanMdrugs,MandMifMapproved,MtheMmanufacturerMhasM7MyearsMofMexclu
siveMmarketingMrights.MAcceleratedMprogramsMinvolveMprovisionalMapprovalMandMappro
valMbasedMonMpreliminaryMevidence.




PageM 4